144 related articles for article (PubMed ID: 26765473)
21. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
[TBL] [Abstract][Full Text] [Related]
22. Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors.
Yonemori K; Kouno T; Ando M; Hirakawa A; Yamamoto H; Ono M; Hirata T; Shimizu C; Tamura K; Katsumata N; Fujiwara Y
Oncology; 2010; 78(1):34-9. PubMed ID: 20185939
[TBL] [Abstract][Full Text] [Related]
23. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.
Gergis U; Dax H; Ritchie E; Marcus R; Wissa U; Orazi A
J Clin Oncol; 2011 Apr; 29(10):e251-3. PubMed ID: 21220616
[No Abstract] [Full Text] [Related]
24. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.
Robinson SP; Goldstone AH; Mackinnon S; Carella A; Russell N; de Elvira CR; Taghipour G; Schmitz N;
Blood; 2002 Dec; 100(13):4310-6. PubMed ID: 12393626
[TBL] [Abstract][Full Text] [Related]
25. Association Among Hypoxemia, Patent Foramen Ovale, and Mediastinal Germ Cell Tumor: A Case Report.
Offin MD; Menachem J; Squillante C; Ky B; Vaughn D; Carver J
Ann Intern Med; 2015 Aug; 163(3):243-4. PubMed ID: 26237762
[No Abstract] [Full Text] [Related]
26. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR
Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
[TBL] [Abstract][Full Text] [Related]
27. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
28. Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature.
Ikdahl T; Josefsen D; Jakobsen E; Delabie J; Fosså SD
Acta Oncol; 2008; 47(3):466-9. PubMed ID: 18348004
[No Abstract] [Full Text] [Related]
29. Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantation.
Neumann T; Schneidewind L; Thiele T; Schulze M; Klenner AF; Busemann C; Pink D; Greinacher A; Dölken G; Krüger WH
J Cancer Res Clin Oncol; 2016 May; 142(5):1091-7. PubMed ID: 26779644
[TBL] [Abstract][Full Text] [Related]
30. Alemtuzumab in allogeneic hematopoetic stem cell transplantation.
Poiré X; van Besien K
Expert Opin Biol Ther; 2011 Aug; 11(8):1099-111. PubMed ID: 21702703
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
Kumar AJ; Hexner EO; Frey NV; Luger SM; Loren AW; Reshef R; Boyer J; Smith J; Stadtmauer EA; Levine BL; June CH; Porter DL; Goldstein SC
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1094-101. PubMed ID: 23635453
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome.
Matsumura Y; Kuroda J; Shimura Y; Kiyota M; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
Intern Med; 2012; 51(19):2785-7. PubMed ID: 23037475
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease.
Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Borjas-Almaguer OD; González-Llano O; Jaime-Pérez JC; Solano-Genesta M; Gómez-Guijosa M; Mancias-Guerra C; Tarin L; Gómez-Almaguer D
Haematologica; 2012 May; 97(5):717-22. PubMed ID: 22133770
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for recurrent primary mediastinal malignant germ cell tumor: a case report.
Keino D; Kondoh K; Murata S; Ohyama R; Morimoto M; Muto S; Fukuda M; Wakisaka M; Kitagawa H; Kinoshita A
Pediatr Transplant; 2014 Mar; 18(2):E52-6. PubMed ID: 24373121
[TBL] [Abstract][Full Text] [Related]
35. Outcomes following surgery for primary mediastinal nonseminomatous germ cell tumors in the cisplatin era.
Kesler KA; Stram AR; Timsina LR; Turrentine MW; Brown JW; Einhorn LH
J Thorac Cardiovasc Surg; 2021 Jun; 161(6):1947-1959.e1. PubMed ID: 32446546
[TBL] [Abstract][Full Text] [Related]
36. [Complete resection of an advanced mediastinal nonseminomatous germ cell tumor with multiple distant metastases after down-staging by chemotherapy].
Usuda K; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Tsuchihara K; Masaki Y; Kinoshita E; Sakuma T
Kyobu Geka; 2009 Jul; 62(7):545-51. PubMed ID: 19588824
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.
Abidi MH; Tove I; Ibrahim RB; Maria D; Peres E
Am J Hematol; 2007 Oct; 82(10):932-3. PubMed ID: 17617785
[TBL] [Abstract][Full Text] [Related]
39. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E
J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945
[TBL] [Abstract][Full Text] [Related]
40. Hematologic neoplasia associated with primary mediastinal germ-cell tumors.
Nichols CR; Roth BJ; Heerema N; Griep J; Tricot G
N Engl J Med; 1990 May; 322(20):1425-9. PubMed ID: 2158625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
